Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Lee, Hye Won ^a   Park, Soo Young ^b   Kim, Seung Up ^a   Jang, Jae Young ^c   Park, Hana ^d   Kim, Ja Kyung ^a   Lee, Chun Kyon ^e   Chon, Young Eun ^a   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Soonchunhyang University   (South Korea)

^d CHA University   (South Korea)

^e National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DIAGNOSTIC IMAGING; ELASTOGRAPHY; FATTY LIVER; FEMALE; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; ODDS RATIO; PREDICTIVE VALUE; PROCEDURES;

ADULT; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PREDICTIVE VALUE OF TESTS;

EID: 85015956736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157358     Document Type: Article

References (45)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34: 274-285. doi: 10.1111/j.1365-2036.2011.04724.x PMID: 21623852
2. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. Jama. 2015; 313: 2263-2273. doi: 10.1001/jama.2015.5370 PMID: 26057287
3. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013; 10: 307-318. doi: 10.1038/nrgastro.2013.34 PMID: 23458891
4. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol. 2007; 47: 239-244. PMID: 17400323
5. Marcos A, Fisher RA, Ham JM, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation. 2000; 69: 2410-2415. PMID: 10868650
6. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55: 2005-2023. doi: 10.1002/hep.25762 PMID: 22488764
7. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121: 91-100. PMID: 11438497
8. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000; 118: 1117-1123. PMID: 10833486
9. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994; 107: 1103-1109. PMID: 7523217
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001; 344: 495-500. PMID: 11172192
11. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97: 2614-2618. PMID: 12385448
12. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005; 128: 1898-1906. PMID: 15940625
13. Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7: 481-486. doi: 10.1016/j.cgh.2008.12.015 PMID: 19162235
14. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6: 33. PMID: 17081293
15. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, et al. The diagnostic value of bio-markers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005; 4: 10. PMID: 16375767
16. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009; 137: 865-872. doi: 10.1053/j.gastro.2009.06.005 PMID: 19524579
17. Ratziu V, Martin L, Fedchuk L, Poynard T. Can nonalcoholic steatohepatitis be diagnosed without liver biopsy? Biomark Med. 2009; 3: 353-361. doi: 10.2217/bmm.09.36 PMID: 20477484
18. Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat. 2012; 19: 244-253. doi: 10.1111/j.1365-2893.2011.01534.x PMID: 22404722
19. Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012; 32: 902-910. doi: 10.1111/j.1478-3231.2012.02781.x PMID: 22435761
20. de Ledinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012; 32: 911-918. doi: 10.1111/j.1478-3231.2012.02820.x PMID: 22672642
21. Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2015; 13: 772-779.e771-773. doi: 10.1016/j.cgh.2014.12. 014 PMID: 25528010
22. Jia J, Hou J, Ding H, Chen G, Xie Q, Wang Y, et al. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol. 2015; 30: 756-762. doi: 10.1111/jgh.12840 PMID: 25353058
23. Kwok R, Choi KC, Wong GL, Zhang Y, Chan HL, Luk AO, et al. Screening diabetic patients for nonalcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2015. 2015/04/16. doi: 10.1136/gutjnl-2015-309265
24. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29: 1705-1713. PMID: 14698338
25. Chon YE, Jung KS, Kim KJ, Joo DJ, Kim BK, Park JY, et al. Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea. Dig Dis Sci. 2015; 60: 234-242. doi: 10.1007/s10620-014-3293-1 PMID: 25118979
26. Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol. 2006; 125: 710-721. PMID: 16707372
27. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313-1321. PMID: 15915461
28. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007; 45: 846-854. PMID: 17393509
29. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int. 2014; 34: 102-109. doi: 10.1111/liv.12282 PMID: 24028214
30. Lupsor-Platon M, Feier D, Stefanescu H, Tamas A, Botan E, Sparchez Z, et al. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study. J Gastrointestin Liver Dis. 2015; 24: 35-42. doi: 10.15403/jgld. 2014.1121.mlp PMID: 25822432
31. Seo YS, Kim MY, Kim SU, Hyun BS, Jang JY, Lee JW, et al. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int. 2015. 2015/02/17. doi: 10.1111/liv.12808
32. Jung KS, Kim SU. Clinical applications of transient elastography. Clin Mol Hepatol. 2012; 18: 163-173. doi: 10.3350/cmh.2012.18.2.163 PMID: 22893866
33. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol. 2013; 58: 1007-1019. doi: 10.1016/j.jhep.2012.11.021 PMID: 23183525
34. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010; 36: 1825-1835. doi: 10.1016/j.ultrasmedbio.2010.07.005 PMID: 20870345
35. Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, et al. A comparison of FibroMeter NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol. 2014; 49: 1343-1348. doi: 10.3109/00365521.2014.958099 PMID: 25259621
36. Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, et al. The usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol. 2014; 33: 445-451. doi: 10.1007/s12664-014-0491-x PMID: 25138787
37. Masaki K, Takaki S, Hyogo H, Kobayashi T, Fukuhara T, Naeshiro N, et al. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol Res. 2013; 43: 1182-1189. doi: 10.1111/hepr.12094 PMID: 23551911
38. Pathik P, Ravindra S, Ajay C, Prasad B, Jatin P, Prabha S. Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India. Ann Gastroenterol. 2015; 28: 281-286. PMID: 25830783
39. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005; 15: 310-315. PMID: 15826462
40. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999; 30: 1356-1362. PMID: 10573511
41. Cordeiro A, Pereira SE, Saboya CJ, Ramalho A. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. Biomed Res Int. 2015; 2015: 839253. doi: 10. 1155/2015/839253 PMID: 26120587
42. Yamazaki H, Tsuboya T, Tsuji K, Dohke M, Maguchi H. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes Mellitus. Diabetes Care. 2015. doi: 10.2337/dc15-0140
43. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008; 57: 1441-1447. doi: 10.1136/gut.2007.146019 PMID: 18390575
44. Hyysalo J, Mannisto VT, Zhou Y, Arola J, Karja V, Leivonen M, et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol. 2014; 60: 839-846. doi: 10.1016/j.jhep.2013.12.009 PMID: 24333862
45. Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7: 1104-1112. doi: 10.1016/j.cgh.2009.05.033 PMID: 19523535